FDA NDC Directory · JSON-LD · Markdown

sildenafil CITRATE

NDC 59651-420 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA214773
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsSILDENAFIL CITRATE (10 mg/mL)
Marketing started20221223
Package count1

External sources

Source: openFDA. Public-domain (CC0).